AstraZeneca and Oxford’s vaccine developed against Covid-19 can be stored, transported, and handled at normal refrigerator temperatures, making it an attractive option for countries around the world vis-a-vis its counterparts Pfizer and Moderna.
It is for these reasons that the vaccine proves to be cheaper and easier to administer.
UK’s approval may soon be followed by other countries, including India, though the European Union and the US are not expected to act on the vaccine anytime soon. AstraZeneca said Wednesday it is seeking an emergency-use listing from the World Health Organization so that the shot can be made available to low- and